• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
    • Editorial Board
    • Contact
  • Issues
    • Current Issue
    • Issue Archives
  • Multimedia
  • Editor's Update
  • Advertise
  • Reprints
  • Authors & Reviewers
    • Author Instructions
    • Submission Portal
    • Reviewers

Search

Dr. Julianne Stoughton Discusses the Rethink Varicose Veins Campaign: Why it Affects Both Patients and Physicians

  • Volume 9 - Issue 7 - July 2012
  • Posted on: 6/28/12
  • 0 Comments
  • 3803 reads
Start Page: 
131
End Page: 
132
Author(s): 

Interview by Amanda Wright

Listen to the audio clip from this interview at http://vasculardiseasemanagement.com/multimedia.

Q: Tell me about the Rethink Varicose Veins campaign and how it began.

A: As a medical community, we decided that there were unmet needs both in the patient population and physician population for education and awareness of what venous disease is, how to prevent it, and how to treat it. We now have so much less-invasive technology that allows us to treat it at an earlier stage. Up until recently, physicians waited to treat patients until the circumstances were very progressive and advanced. We are aware that this is a progressive issue and that varicose veins are often associated with progression to venous ulcers, skin changes, leg swelling, and lifestyle changes. We wanted to make it publicly aware that there were things that could be done.

There are essentially 3 organizations involved (Society of Vascular Surgeons, American College of Phlebology, and American Venous Forum). Most venous practitioners are in these 3 organizations and we’ve gotten together to help contribute to this campaign so that we can help the whole public. We are, as a group, trying to make patients and physicians more aware that referral to a vein specialist is a good idea early on.

Q: Why is it so important to educate physicians and patients about varicose veins now?

A: In my personal practice in the last decade, I have noticed that many primary care physicians, obstetricians, gynecologists, and others who see people with venous disease have watched and not really treated these patients early on with conservative measures. They haven’t referred them until they have clots in their legs or ulcers on their skin and I always thought, “I wish they would have known.” I’ve tried to go out and give talks in the community, trying to reach out to my colleagues, but this is really an international concern that exploded because treatments have become better. Patients who had surgery many years ago want to know why they have more veins. They weren’t educated properly and feel that treatment failed and they’re never going back again. I feel as though it’s important for these patients to know that there are less-invasive treatments available rather than the old-fashioned surgical procedures.

Q: During the campaign, what educational resources will be provided for health-care professionals?

A: Mainly, it starts out with the website, www.rethinkvaricoseveins.com. There are multiple resources for both segments of the population. For the specialists, there is a lot of information to help them communicate with patients about what varicose veins are, what chronic venous insufficiency is, how to prevent it, and all of the conservative measures. There is also information about how to educate the patient. There are e-flyers, a kit with advertising and banner ads, Facebook and Twitter pages, and resource materials and educational material for medical professionals. There’s also a lot of that same kind of thing for the patient. It also includes self-assessment tools for the patients where they are asked to identify various risk factors in their own situation and some of the symptoms and signs. They can then bring the self-screening to a venous specialist.

Q: Will there be a listing of venous professionals on the website for patients to access?

A: Yes, actually, that is one of the tools for the specialists. They are allowed to have themselves listed. It is something that we’ll screen to make sure the person is legitimate but they will be listed in a group of professionals that are qualified to treat venous disease, which will be available to the public.

Q: Are you holding any screening or treatment events to promote the need for varicose vein awareness?

A:  We have had an American Venous Forum screening program in place for a long time and it has reached a national level. There are many physicians, both in the American Venous Forum and the American College of Phlebology, who have been doing screenings. We are attempting to have a resurgence of those programs and perhaps stimulate more screenings in the community. The more patients are aware, the more they will be looking for those screening programs.  

Q: Are the physicians involved on a voluntary basis?

A:  Yes, I am certainly. There are many volunteers and we’re all involved in trying to get these educational materials and the website going. This is primarily for the better treatment of the patients and education of health-care professionals. We’re basically doing this in our spare time.

Q: How can our audience of professionals in the peripheral interventional field get involved in the campaign on a voluntary basis?

A: The best way to start would be to get onto the website, which has many of those resources that I mentioned. If they wanted to be listed as specialists, there’s one way to do that. If they wanted to have materials or resources for their patients, they can also do that.

Q: Is there anything else that you would like to add?

  • 1
  • 2
  • next ›
  • last »
Bookmark/Search this post with
  • Digg
  • LinkedIn
  • Reddit
  • Facebook Like
  • Google Plus One
  • Linkedin Share Button
  • Tweet Widget
image description image description Other Interview Articles

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.
  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Kimberly Sutkowski, Classified Sales Representative
    (800) 237-7285, ext. 205

Vascular Access: The VDM Clinician Blog

Anticoagulant Treatment of DVT and Preventing DVT-PE Made Easier

Frank J Criado MD FACS FSVM

Retrograde Crossing: When the Front Door Is Locked, Look for Another Way In!

Ajay U. Mhatre MD

Collecting More Data for Vascular Patients

Lawrence A. Garcia MD

A Road Less Traveled: Access in the Right Brachial Artery

Ajay U. Mhatre MD

Endovascular Options for Complex Abdominal Aortic Aneurysms

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Cordis Showcases New Cardiovascular Innovations at EuroPCR 2013
    Tue, 05/21/13 - 10:13am
  • Verrata Pressure Guide Wire and iFR (Instant Wave-Free Ratio) Software Modality on Display at EuroPCR 2013
    Tue, 05/21/13 - 9:36am
  • Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
    Tue, 05/21/13 - 9:27am
  • First Clinical Research Published on Frequency and Composition of Embolic Debris Captured During TAVR
    Mon, 05/20/13 - 3:07pm
more »

Clinical Events Calendar

  • EuroPCR 2013
    Tue, 05/21/2013 - Fri, 05/24/2013
    Paris, France
  • European Society for Vascular Surgery European Vascular Trauma Workshop
    Mon, 05/27/2013 - Tue, 05/28/2013
    Sweden
  • Society for Vascular Surgery Vascular Annual Meeting 2013 (SVS)
    Thu, 05/30/2013 - Sat, 06/01/2013
    San Francisco, CA, United States
more »

Poll

Drug-eluting balloons will have a major role in lower-extremity revascularization in the future.:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications